8-K: Cross Country Healthcare Merger Faces Delay as FTC Issues Second Request for Information

Cross Country Healthcare's merger with Aya Healthcare is now expected to close in the second half of 2025 due to a second request for additional information from the U.S. Federal Trade Commission (FTC).

Summary

• Cross Country Healthcare, Inc. (CCRN) announced that its merger with Aya Healthcare is now expected to close in the second half of 2025.
• The delay is due to the receipt of a second request for additional information from the FTC on February 20, 2025, regarding the proposed merger.
• The issuance of the Second Request extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) until 30 days after both companies substantially comply with the request, unless the period is extended or terminated earlier by the FTC.
• Both Cross Country Healthcare and Aya Healthcare are cooperating with the FTC.
• The merger is still subject to the approval of Cross Country Healthcare's stockholders and the satisfaction or waiver of other customary closing conditions.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the delay in the merger closing, which introduces uncertainty and potential risks. However, the companies are cooperating with the FTC, which is a positive sign.

Positives

• Cross Country Healthcare and Aya Healthcare are cooperating with the FTC's review.
• The company has filed a proxy statement on Schedule 14A with the SEC, and the definitive proxy statement was thereafter mailed to stockholders of the Company seeking their approval of the transaction-related proposals.

Negatives

• The merger closing is delayed to the second half of 2025 due to the FTC's Second Request.
• The extended waiting period under the HSR Act introduces uncertainty regarding the merger's timeline.

Risks

• The merger may not be completed if the closing conditions are not satisfied or waived.
• Regulatory approval may not be obtained or may be subject to unanticipated conditions.
• The delay could divert management's attention from ongoing business operations.
• The announcement of the delay could have adverse effects on the market price of Cross Country Healthcare's common stock.
• The delay could negatively impact the company's ability to retain customers and key personnel.
• Potential litigation relating to the Merger could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto.

Future Outlook

The Company now expects that the Merger will close in the second half of 2025, subject to the approval of the Company's stockholders and the satisfaction or waiver of the other customary closing conditions specified in the Merger Agreement.

Management Comments

• The Company and Aya have been working cooperatively with the FTC and will continue to do so.

Industry Context

Mergers in the healthcare staffing industry are subject to regulatory scrutiny to ensure they do not reduce competition or negatively impact pricing and service quality.

Comparison to Industry Standards

• Other healthcare mergers, such as the Optum and Change Healthcare deal, have faced similar scrutiny from regulatory bodies like the Department of Justice.
• The timeline for regulatory review can vary significantly, with some mergers being approved quickly and others facing lengthy investigations and challenges.

Stakeholder Impact

• Shareholders may experience uncertainty due to the delayed merger closing.
• Employees may face concerns about job security during the extended period of regulatory review.
• Customers and suppliers may experience disruptions or changes in their relationships with the company.

Next Steps

• Cross Country Healthcare and Aya Healthcare will continue to cooperate with the FTC to address the Second Request.
• The Company will seek stockholder approval for the merger.
• The parties will work to satisfy or waive the other customary closing conditions.

Key Dates